Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) ELISA Kit
Due to the possibility of mismatching between antigens from other origin and antibodies used in our kits (e.g., antibody targets conformational epitope rather than linear epitope), some native or recombinant proteins from other manufacturers may not be recognized by our products.
Principle of the Assay
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human RELB. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human RELB. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human RELB, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human RELB in the samples is then determined by comparing the OD of the samples to the standard curve.
For use with: tissue homogenates, cell lysates, and other biological fluids.
For Research Use Only. Not for use in diagnostic procedures.
Target Information
NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52. Is required for both T and B lymphocyte maturation and function (PubMed:26385063).
| GENE ID | 5971 |
| SWISS PROT | Q01201 |
| SYNONYMS | REL-B; I-REL; Transcription Factor RelB; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 3 |
Materials Supplied
| Kit Components | 96 Wells Quantity/Size |
|---|---|
| Pre-Coated Microplate | 48T: 6 strips x 8 wells; 96T: 12 strips x 8 wells |
| Standard (Lyophilized) | 48T: 1 vial; 96T: 2 vials |
| Biotinylated Antibody (100×) | 48T: 60 μL; 96T: 120 μL |
| Streptavidin-HRP (100×) | 48T: 60 μL; 96T: 120 μL |
| Standard/Sample Diluent Buffer | 48T: 10 mL; 96T: 20 mL |
| Biotinylated Antibody Diluent | 48T: 6 mL; 96T: 12 mL |
| HRP Diluent | 48T: 6 mL; 96T: 12 mL |
| Wash Buffer (25×) | 48T: 10 mL; 96T: 20 mL |
| TMB Substrate Solution | 48T: 6 mL; 96T: 10 mL |
| Stop Reagent | 48T: 3 mL; 96T: 6 mL |
| Plate Covers | 48T: 1 piece; 96T: 2 pieces |
Storage
| Storage | *If the kit is opened, Store the whole kit at 4°C. If the kit is not used up in 1 week. Store the Pre-Coated Microplate, Standard ,Biotinylated Antibody and Streptavidin-HRP at -20°C, the rest reagents at 4°C, please used up within 6 months. *If the kit is not opened, store the whole kit: 4°C(short time storage, valid for 6 months); -20°C (long-term storage, valid for 1 year). Avoid repeated freeze-thaw cycles. |
Performance Characteristics
| REPEATABILITY | Intra-assay Precision (Precision within an assay):CV% < 8% Three samples of known concentration were tested twenty times on 1 plate to assess intra-assay precision. Inter-assay Precision (precision between assays):CV% < 10% Three samples of known concentration were tested in forty separate assays to assess inter-assay precision. |
| SENSITIVITY | The minimum detectable dose was 0.06ng/mL. |
| ASSAY RANGE | 0.16–10ng/mL |
| SPECIFICITY | This assay has high sensitivity and excellent specificity for detection of Human RELB. No significant cross-reactivity or interference between Human RELB and analogues was observed. |
Frequently asked questions
What is Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) ELISA Kit (BSKH73123) used for?
Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) ELISA Kit is used for Sandwich Elisa.
Which species does Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) ELISA Kit (BSKH73123) detect?
BSKH73123 is designed for Human samples.
